| Authors: |
Kigar SL; National Institute of Mental Health, Bethesda, MD, USA.; Department of Medicine, University of Cambridge, UK.; Department of Psychiatry, University of Cambridge, UK., Lynall ME; Department of Psychiatry, University of Cambridge, UK.; Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK., DePuyt AE; National Institute of Mental Health, Bethesda, MD, USA., Atkinson R; National Institute of Mental Health, Bethesda, MD, USA., Sun VH; National Institute of Mental Health, Bethesda, MD, USA., Samuels JD; National Institute of Mental Health, Bethesda, MD, USA., Eassa NE; National Institute of Mental Health, Bethesda, MD, USA., Poffenberger CN; National Institute of Mental Health, Bethesda, MD, USA., Lehmann ML; National Institute of Mental Health, Bethesda, MD, USA., Listwak SJ; National Institute of Mental Health, Bethesda, MD, USA., Livak F; Laboratory of Genome Integrity, Flow Cytometry Core, National Cancer Institute, Bethesda, MD, USA., Elkahloun AG; Microarrays and Single-Cell Genomics, National Human Genome Research Institute, Bethesda, MD, USA., Clatworthy MR; Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK.; Cellular Genetics, Wellcome Sanger Institute, UK., Bullmore ET; Department of Psychiatry, University of Cambridge, UK., Herkenham M; National Institute of Mental Health, Bethesda, MD, USA. |
